Rich countries must not exploit poorer nations for research purposesBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7344.996/d (Published 27 April 2002) Cite this as: BMJ 2002;324:996
- Zosia Kmietowicz
Companies or organisations in wealthy countries that plan to carry out research in developing countries should ensure that certain ethical standards are in place before they go ahead with studies that may hold little value to participants, warns the Nuffield Council on Bioethics.
In a report published this week the council advises developed nations to pay special attention to how they plan to gain consent from the people they wish to participate in trials. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial